KUALA LUMPUR: Topvision Eye Specialist Bhd
makes its debut on the ACE Market of Bursa Malaysia at 39 sen, representing an 18% premium over its initial public offering price of 33 sen.
The medical eye care services provider added 2.5 sen, or 7.58% top 35.5 sen with 43.79 million shares traded at 10.35 am.
TopVision aims to raise RM17.89mil through its public offering, with RM7.9mil allocated for the establishment of the TopVision International Eye Specialist Centre in the Klang Valley.
This centre will be a tertiary eye ambulatory care facility offering subspecialty services such as retinal surgery, cornea transplants, and paediatric ophthalmology.
Additionally, RM5mil will be used for expanding the ambulatory care centre (ACC) network with new centres in Kuala Terengganu and Tawau, Sabah, expanding the company's presence.
“This transfer of listing marks a significant milestone in TopVision’s journey, reflecting our unwavering commitment to delivering quality and accessible eye care services across Malaysia. It symbolises not only the culmination of our hard work but also the confidence the market has in our strategic vision and growth potential.
“With this transition, we aim to strengthen our presence in Malaysia’s eye healthcare sector, expand our service network, and elevate the standards of patient care to new heights,” executive vice chairman Datuk Kenny Liew Hock Nean said in a statement.
Hong Leong Investment Bank Bhd is the principal adviser, sponsor, sole underwriter and sole bookrunner.
